Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 400 is a processed or unprocessed pseudogene homologous to 5S ribosomal RNA, part of the ribosomal RNA gene family. 5S rRNA is a ~120 nucleotide structural and functional component of the large ribosomal subunit, essential for ribosomal assembly and protein synthesis in all cellular life. However, RNA, 5S ribosomal pseudogene 400 has lost its canonical function due to mutations or absence of regulatory elements, and thus does not produce functional RNA or protein. Pseudogenes like RNA5SP400 may be transcribed in some contexts but lack coding potential; in rare cases, pseudogene-derived transcripts may have regulatory effects, though this is not established for RNA5SP400. Pseudogenes are cataloged in genomic databases for annotation purposes and are typically not considered molecular drug targets.
There are no established mechanisms of action for targeting this pseudogene, as it is not a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 400 (RNA5SP400).